Výsledky vyhledávání - Richard Iggo
- Zobrazuji výsledky 1 - 20 z 23
- Přejít na další stránku
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Inactivate the remaining p53 allele or the alternate p73? Preferential selection of the Arg72 polymorphism in cancers with recessive p53 mutants but not transdominant mutants Autor Mitsuhiro Tada, Keiji Furuuchi, Masako Kaneda, Joe Matsumoto, Masato Takahashi, Atsuko Hirai, Yasuhide Mitsumoto, Richard Iggo, Tetsuya Moriuchi
Vydáno 2001Artigo -
9
-
10
p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements Autor Paola Campomenosi, Paola Monti, Anna Aprile, Angelo Abbondandolo, Thierry Frébourg, Barry Gold, Tim Crook, Alberto Inga, Michael A. Resnick, Richard Iggo, Gilberto Fronza
Vydáno 2001Artigo -
11
Targeted Radionuclide Therapy Using a Wnt-Targeted Replicating Adenovirus Encoding the Na/I Symporter Autor Inge Peerlinck, Andrew Merron, Patrick Baril, Sophie Conchon, Pilar Martín‐Duque, Cécilia Hindorf, Jerome Burnet, Miguel Quintanilla, Mohan Hingorani, Richard Iggo, Nicholas R. Lemoine, Kevin J. Harrington, Georges Vassaux
Vydáno 2009Artigo -
12
Solid-type adenoid cystic carcinoma of the breast, a distinct molecular entity enriched in NOTCH and CREBBP mutations Autor Julie Massé, Caroline Truntzer, Romain Boidot, Emmanuel Khalifa, Gaëlle Pérot, Valérie Velasco, Laétitia Mayeur, Claire Billerey-Larmonier, Larry Blanchard, H. Charitansky, Isabelle Soubeyran, Richard Iggo, Laurent Arnould, Gaëtan MacGrogan
Vydáno 2019Artigo -
13
Identification of molecular apocrine breast tumours by microarray analysis Autor Pierre Farmer, Hervé Bonnefoi, Véronique Becette, M. Tubiana-Hulin, P. Fumoleau, Denis Larsimont, Gaëtan MacGrogan, Jonas Bergh, David Cameron, Daniel R. Goldstein, Stephan Duss, A-L Nicoulaz, Maryse Fiche, Cathrin Brisken, Mauro Delorenzi, Richard Iggo
Vydáno 2005Artigo -
14
Disequilibrium of BMP2 Levels in the Breast Stem Cell Niche Launches Epithelial Transformation by Overamplifying BMPR1B Cell Response Autor Marion Chapellier, Élodie Bachelard-Cascales, Xenia Schmidt, Flora Clément, Isabelle Treilleux, E. Delay, Alexandre Jammot, Christine Ménétrier‐Caux, Gaëtan Pochon, Roger Besançon, Thibault Voeltzel, Claude Caron de Fromentel, Christophe Caux, Jean‐Yves Blay, Richard Iggo, Véronique Maguer‐Satta
Vydáno 2015Artigo -
15
Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations Autor Guillaume Banneau, Mickaël Guedj, Gaëtan MacGrogan, Isabelle de Mascarel, Valérie Velasco, Renaud Schiappa, Valérie Bonadona, Albert David, Catherine Dugast, Brigitte Gilbert‐Dussardier, Olivier Ingster, P. Vabres, F. Caux, Aurélien de Reyniès, Richard Iggo, Nicolas Sévenet, Françoise Bonnet, Michel Longy
Vydáno 2010Artigo -
16
RETRACTED: Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial Autor Hervé Bonnefoi, Anil Potti, Mauro Delorenzi, L. Mauriac, Mario Campone, M. Tubiana-Hulin, Thierry Petit, Philippe Rouanet, Jacek Jassem, Emmanuel Blot, Véronique Becette, Pierre Farmer, Sylvie André, Chaitanya R. Acharya, Sayan Mukherjee, David Cameron, Jonas Bergh, Joseph R. Nevins, Richard Iggo
Vydáno 2007Artigo -
17
Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes Autor Hervé Bonnefoi, Gaëtan MacGrogan, Coralie Poncet, Richard Iggo, Fanny Pommeret, Thomas Grellety, Denis Larsimont, Véronique Becette, Olivier Kerdraon, Frédéric Bibeau, Jean‐Pierre Ghnassia, Jean‐Michel Picquenot, Jeremy Thomas, Jean‐Christophe Tille, Leen Slaets, Alexandre Bodmer, Jonas Bergh, David Cameron
Vydáno 2019Artigo -
18
TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial Autor Hervé Bonnefoi, Martine Piccart, Jan Bogaerts, L. Mauriac, P. Fumoleau, Étienne Brain, Thierry Petit, Philippe Rouanet, Jacek Jassem, Emmanuel Blot, Khalil Zaman, Tanja Čufer, Alain Lortholary, Elisabet Lidbrink, Sylvie André, Saskia Litière, Lissandra Dal Lago, Véronique Becette, David Cameron, Jonas Bergh, Richard Iggo
Vydáno 2011Artigo -
19
Darolutamide or capecitabine in triple-negative, androgen receptor-positive, advanced breast cancer (UCBG 3-06 START): a multicentre, non-comparative, randomised, phase 2 trial Autor Hervé Bonnefoi, Florence Lerebours, Marina Pulido, Mónica Arnedos, Olivier Trédan, Florence Dalenc, Séverine Guiu, Luís Teixeira, Delphine Mollon, Christelle Levy, Benjamin Verret, Heba Dawood, Laura Deiana, Marie‐Ange Mouret‐Reynier, Paule Augereau, Jean-Luc Canon, Noémie Huchet, C. Guyonneau, Jérôme Lemonnier, Gaëtan MacGrogan, Anthony Gonçalves, Élodie Darbo, Richard Iggo
Vydáno 2025Artigo -
20
Post-transcriptional Gene Regulation by MicroRNA-194 Promotes Neuroendocrine Transdifferentiation in Prostate Cancer Autor Rayzel C. Fernandes, John Toubia, Scott L. Townley, Adrienne R. Hanson, B. Kate Dredge, Katherine A. Pillman, Andrew G. Bert, Jean M. Winter, Richard Iggo, Rajdeep Das, Daisuke Obinata, Shahneen Sandhu, Gail P. Risbridger, Renea A. Taylor, Mitchell G. Lawrence, Lisa M. Butler, Amina Zoubeidi, Philip A. Gregory, Wayne D. Tilley, Theresa E. Hickey, Gregory J. Goodall, Luke A. Selth
Vydáno 2021Artigo
Vyhledávací nástroje:
Související témata
Biology
Genetics
Gene
Cancer
Medicine
Cancer research
Internal medicine
Breast cancer
Molecular biology
Mutant
Pathology
Cell biology
Oncology
Carcinogenesis
Mdm2
Prostate cancer
Transcription factor
Wild type
Androgen receptor
Apocrine
Apoptosis
Computational biology
DNA
DNA damage
Gene expression
Immunohistochemistry
Mutation
Tissue microarray
Adenoviridae
Anthracycline